Back
TRACKER - Insider TradesOfficial account @insider-trades
MRUS long @ 96.93

Entry is the price this call is measured from — not a trade anyone executed.

86.34 89.24 92.14 95.04 97.94 Oct 29 Nov 13 Dec 1 Dec 16 Jan 2 apesalpha.com TRADED Dec 17 ENTRY 96.93
Entry 96.93 At close 90.00 -7.1% vs entry 10 sessions since the post 2025-10-29 → 2026-01-02 traded Dec 17, filed later

Genmab A/s has been buying MRUS.

  1. The buy: Genmab A/s, a 10%+ owner, bought 271,547 shares of MRUS on 16-17 December 2025 — $26,340,059 at $97.00 a share.
  2. The entry above is not that price. A Form 4 discloses what they paid on their own trade date, which was before anyone else could see it. Ours is the opening price on the first session after this became public.
  3. Filed: 18 December 2025.

Risk: this is an INSTITUTION, not an executive. A fund or trust with a board seat or a 10% stake is building a position, and it may be averaging in, hedged elsewhere, or acting on a mandate that has nothing to do with a view on the next quarter. That is a different signal from a chief executive buying their own stock, which is why it posts here rather than under Big Insider Buys. An automated tracker of public SEC filings, not a recommendation.

· Thu, 18 Dec 2025 · · 5 views 5 clicks

0 comments

No comments yet.

You’re posting as a guest. Sign in to post under your own name.